ATE531419T1 - Vorrichtung zur verabreichung von therapeutischen mitteln - Google Patents

Vorrichtung zur verabreichung von therapeutischen mitteln

Info

Publication number
ATE531419T1
ATE531419T1 AT04809058T AT04809058T ATE531419T1 AT E531419 T1 ATE531419 T1 AT E531419T1 AT 04809058 T AT04809058 T AT 04809058T AT 04809058 T AT04809058 T AT 04809058T AT E531419 T1 ATE531419 T1 AT E531419T1
Authority
AT
Austria
Prior art keywords
administration
therapeutic agents
infections
exerting
hospital
Prior art date
Application number
AT04809058T
Other languages
English (en)
Inventor
Jon Lundberg
Eddie Weitzberg
Original Assignee
Nitricare Hb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0303364A external-priority patent/SE0303364D0/xx
Priority claimed from SE0401498A external-priority patent/SE0401498D0/xx
Application filed by Nitricare Hb filed Critical Nitricare Hb
Application granted granted Critical
Publication of ATE531419T1 publication Critical patent/ATE531419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0015—Gastrostomy feeding-tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
    • A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
    • A61J15/0038—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type
    • A61J15/0042—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00—Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02—Dilators made of swellable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT04809058T 2003-12-15 2004-12-15 Vorrichtung zur verabreichung von therapeutischen mitteln ATE531419T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0303364A SE0303364D0 (sv) 2003-12-15 2003-12-15 New device and method for prevention of nocosomial infections
SE0401498A SE0401498D0 (sv) 2004-06-11 2004-06-11 Device and method for administering therapeutic agents
PCT/SE2004/001879 WO2005056102A1 (en) 2003-12-15 2004-12-15 Device and method for administering therapeutic agents

Publications (1)

Publication Number Publication Date
ATE531419T1 true ATE531419T1 (de) 2011-11-15

Family

ID=34680756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809058T ATE531419T1 (de) 2003-12-15 2004-12-15 Vorrichtung zur verabreichung von therapeutischen mitteln

Country Status (10)

Country Link
US (1) US20070239107A1 (de)
EP (1) EP1694399B1 (de)
JP (1) JP2007534361A (de)
KR (1) KR20070003815A (de)
AT (1) ATE531419T1 (de)
AU (1) AU2004296174A1 (de)
CA (1) CA2549544A1 (de)
IL (1) IL176289A0 (de)
NO (1) NO20063105L (de)
WO (1) WO2005056102A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080167603A1 (en) * 2000-12-26 2008-07-10 Alex Stenzler Method and device to prevent ventilator acquired pneumonia using nitric oxide
CN101213292A (zh) 2005-05-24 2008-07-02 环境生物科技Crc有限公司 调节生物膜生长的方法和组合物
AU2006251861B2 (en) * 2005-05-24 2012-08-16 Nanyang Technological University Methods and compositions for regulating biofilm development
EP1888510A4 (de) 2005-05-27 2013-01-16 Univ North Carolina Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
CA2672602C (en) * 2006-12-18 2014-05-20 Electronic Dietary Foods Inc. Device for delivery of a substance
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8152792B1 (en) * 2008-09-08 2012-04-10 Kornel Ezriel E Subcutaneous drain for a body cavity
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
ES2655883T5 (es) 2009-07-08 2022-04-18 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Composiciones farmacéuticas que contienen tiosulfato de sodio
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US20130211384A1 (en) * 2010-07-28 2013-08-15 Fondazione Irccs Istituto Nazionale Dei Tumori Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
DE102011119160A1 (de) * 2011-11-22 2013-05-23 Largentec Gmbh Vorrichtung zum Verhindern und/oder Behandeln von Harnwegsinfektionen
ITMI20122062A1 (it) * 2012-12-03 2014-06-04 Cryoservice & Medical Devices S R L Catetere con guaina a dissipazione controllata di liquido
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
WO2016098620A1 (ja) * 2014-12-19 2016-06-23 隆 横尾 移植用臓器及び臓器構造体
EP4400101A1 (de) 2016-01-27 2024-07-17 SYK Technologies, LLC Vorrichtung und verfahren zur topischen anwendung von stickoxid
US11173235B2 (en) * 2016-07-15 2021-11-16 Cook Regentec Llc Nitrite eluting devices and methods of use thereof
DK3793627T3 (da) 2018-05-17 2025-01-02 Hollister Inc Hydrofile, medicinske produkter og hydreringsmedier til hydrering deraf
AU2020292274B2 (en) 2019-06-13 2024-05-23 Hollister Incorporated Reusable urinary catheter products
CA3140908A1 (en) 2019-06-25 2020-12-30 Hollister Incorporated Reusable urinary catheter products
EP4699638A2 (de) 2019-11-08 2026-02-25 Hollister Incorporated Verfahren zur herstellung von umhüllten und verpackten hydrophilen katheteranordnungen
LT4054662T (lt) 2019-11-08 2024-08-12 Hollister Incorporated Hidrofiliniai medicinos produktai ir drėkinimo terpės jiems drėkinti
EP4126079B1 (de) * 2020-04-02 2025-11-05 The Regents of The University of Michigan Behandlung von harnkathetern
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy
US12171235B2 (en) * 2021-05-05 2024-12-24 Hdr Llc Antimicrobial composition and system for delivering an antimicrobial composition
AU2022286252A1 (en) 2021-06-04 2023-12-21 Hollister Incorporated Methods of making sleeved hydrophilic catheter products

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4417576A (en) * 1982-02-25 1983-11-29 Baran Ostap E Double-wall surgical cuff
EP0124536A4 (de) * 1982-11-05 1985-06-06 Baxter Travenol Lab Antimikrobielle zusammensetzungen.
DE3916648C1 (de) * 1989-05-22 1990-09-06 Fa. Carl Freudenberg, 6940 Weinheim, De
US5007897A (en) * 1989-05-30 1991-04-16 Kalb Irvin M Drug delivery catheter
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5236422A (en) * 1991-06-24 1993-08-17 Eplett Jr James D Antiseptic urinary catheter cuff
US5417657A (en) * 1993-10-06 1995-05-23 Hauer; Carolyn No-sepsis urinary drainage catheter
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US5857998A (en) * 1994-06-30 1999-01-12 Boston Scientific Corporation Stent and therapeutic delivery system
US6425881B1 (en) * 1994-10-05 2002-07-30 Nitrosystems, Inc. Therapeutic mixture useful in inhibiting lesion formation after vascular injury
MX9703988A (es) * 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US6368315B1 (en) * 1999-06-23 2002-04-09 Durect Corporation Composite drug delivery catheter
US6494862B1 (en) * 1999-07-13 2002-12-17 Advanced Cardiovascular Systems, Inc. Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
US6780849B2 (en) * 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US7179251B2 (en) * 2001-01-17 2007-02-20 Boston Scientific Scimed, Inc. Therapeutic delivery balloon
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US6656155B2 (en) * 2001-12-17 2003-12-02 Scimed Life Systems, Inc. Catheter for endoluminal delivery of therapeutic agents that minimizes loss of therapeutic
US20030039697A1 (en) * 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
US7195615B2 (en) * 2003-05-14 2007-03-27 Boston Scientific Scimed, Inc. System for providing a medical device with anti-microbial properties
US20050192590A1 (en) * 2004-02-26 2005-09-01 Kristin Feeley Antimicrobial agent delivery system

Also Published As

Publication number Publication date
EP1694399A1 (de) 2006-08-30
IL176289A0 (en) 2006-10-05
WO2005056102A1 (en) 2005-06-23
US20070239107A1 (en) 2007-10-11
AU2004296174A1 (en) 2005-06-23
JP2007534361A (ja) 2007-11-29
KR20070003815A (ko) 2007-01-05
NO20063105L (no) 2006-09-13
CA2549544A1 (en) 2005-06-23
EP1694399B1 (de) 2011-11-02

Similar Documents

Publication Publication Date Title
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
BRPI0411016A (pt) composições antisépticas, processos e sistemas
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
HRP20040059B1 (hr) Tretman infekcije nokta s no
CU23367A3 (es) Formulación de moxifloxacino con sal común
ATE430154T1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE486634T1 (de) Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza
DE602005006278D1 (de) Orale antimikrobielle pharmazeutische zusammensetzungen
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
ATE308895T1 (de) Behandlung von infektionen in tieren
DE60331654D1 (de) Nicht-radioaktives Strontiummittel zur Behandlung von Krebs
SE0303364D0 (sv) New device and method for prevention of nocosomial infections
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
CY1108472T1 (el) Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης
HRP20070441T3 (hr) Farmaceutska kombinacija za liječenje grčeva i/ili boli
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
ATE441461T1 (de) Mittel zur behandlung von infektionen
DE602006018619D1 (de) Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen